Biogen explores sale of hemophilia assets: sources
 

Biogen explores sale of hemophilia assets: sources
(Reuters) - Biogen Inc, one of the world's largest biotech**logy companies, is exploring a sale of its hemophilia treatments, as it increases its focus on core therapeutic areas, according to people familiar with the matter.
http://i1.wp.com/reuters.us.feedspor...f?resize=1%2C1http://feeds.feedburner.com/~ff/reut...?d=yIl2AUoC8zA [IMG]http://feeds.feedburner.com/~ff/reuters/healthNews?i=Oip9373vA**:RjcTu_4VIPY:F7zBnMyn0Lo[/IMG] [IMG]http://feeds.feedburner.com/~ff/reuters/healthNews?i=Oip9373vA**:RjcTu_4VIPY:V_sGLiPBpWU[/IMG]
[IMG]http://feeds.feedburner.com/~r/reuters/healthNews/~4/Oip9373vA**[/IMG]